A rare case of hepatitis associated with cefprozil therapy

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 2, 2007, Pages 190-192

  Bilici, Ahmet ^a   Karaduman, Mehmet ^a   Cankir, Zeki ^a  

^a ETIMESGUT MILITARY HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; BILIRUBIN; CEFPROZIL; GAMMA GLUTAMYLTRANSFERASE; RANITIDINE;

ADOLESCENT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; DRUG WITHDRAWAL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYDRATION; LABORATORY TEST; PHARYNGITIS; PHYSICAL EXAMINATION; SEROLOGY; TOXIC HEPATITIS; TREATMENT RESPONSE; URINALYSIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; FEMALE; HEPATITIS, TOXIC; HUMANS; PHARYNGITIS; TONSILLITIS;

EID: 33847115785     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600823235     Document Type: Article

References (15)

1. Gupta, N., Bagga, V., Parmar, BJ, Kar, K., Mukherjee, A., Mehta, S. and Moharana, AK. (2004) Efficacy and tolerability assessment of cefprozil in children with acute otitis media. Indian J Pediatr, 71, pp. 319-324.
2. Bhargava, S., Lodha, R. and Kabra, SK. (2003) Cefprozil: A review. Indian J Pediatr, 70, pp. 395-400.
3. Cazzola, M. (2000) Novel oral cephalosporins. Expert Opin Investig Drugs, 9, pp. 237-246.
4. Liu, YC, Huang, WK and Chen, DL. (1995) Antibacterial activity of cefprozil in vitro. Chemotherapy, 41, pp. 427-432.
5. Stutman, HR (1993) Cefprozil. Pediatr Ann, 22, pp. 167-168.
6. Gainer, RB (1995) Cefprozil, a new cephalosporin: Its use in various clinical trials. South Med J, 88, pp. 338-346.
7. Gupta, N., Mukherjee, A. and Moharana, AK. (2004) Paediatric tonsillopharyngitis: An evaluation of cefprozil in Indian patients. Indian J Pediatr, 71, pp. 601-605.
8. Wilber, RB, Doyle, CA, Durham, SJ, Conetta, BJ, DeGraw, SS and Leigh, A. (1992) Safety profile of cefprozil. Clin Infect Dis, 14, p. S264.
9. Baciewicz, AM and Chandra, R. (2005) Cefprozil-induced rash in infectious mononucleosis. Ann Pharmacother, 39, pp. 974-975.
10. Lowery, N., Kearns, GL, Young, RA and Wheeler, JG. (1994) Serum sickness-like reactions associated with cefprozil therapy. J Pediatr, 125, pp. 325-328.
11. Shyu, WC, Pittman, KA, Wilber, RB, Matzke, GR and Barbhaiya, RH. (1991) Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment. J Clin Pharmacol, 31, pp. 362-371.
12. Shyu, WC, Wilber, RB, Pittman, KA, Garg, DC and Barbhaiya, RH. (1991) Pharmacokinetics of cefprozil in healthy subjects and patients with hepatic impairment. J Clin Pharmacol, 31, pp. 372-376.
13. Lee, WM. (1995) Drug-induced hepatotoxicity. N Engl J Med, 333, pp. 1118-1127.
14. Marino, G. and Lewis, JH. (2001) Drug-induced liver disease. Curr Opin Gastroenterol, 17, pp. 232-241.
15. Benichou, C. (1990) Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol, 11, pp. 272-276.